Abstract
The innate immune system of the brain is principally composed of microglial cells and astrocytes, which, once activated, protect neurons against insults (infectious agents, lesions, etc.). Activated glial cells produce inflammatory cytokines that act specifically through receptors expressed by the brain, leading to the development of behavioral disorders including depressive behavior and cognitive alterations. These behavioral alterations cease along with the synthesis of brain cytokines. When the level of expression of these cytokines remains high, they become toxic to neurons and can lead to their death, as in the case of neurodegenerative disorders like Alzheimer’s disease. Omega3 (ω3) type polyunsaturated fatty acids (PUFAs) are essential nutrients and essential components of neuronal and glial cell membranes. Additionally, they have powerful immunomodulatory properties and regulate the cytokines and their signaling pathways. They accumulate in the brain during the perinatal period in a dietary supply-dependant fashion. Their brain levels diminish with age, but can be corrected by a diet enriched in ω3 PUFAs. The increasing exposure of the population to “fast-food” type diets, extremely unbalanced in ω3 PUFAs, could contribute to the fragilization of the brain with respect to cytokines.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- 15d-PGJ2:
-
15-deoxy-delta 12,14-prostaglandin J2
- AA:
-
Arachidonic acid
- ALA:
-
Alpha linolenic acid
- BBB:
-
Blood brain barrier
- CNS:
-
Central nervous system
- COX:
-
Cyclooxygenase
- cPLA2:
-
Calcium-dependent phospholipase A2
- DHA:
-
Docosahexaenoic acid
- DPA:
-
Docosapentaenoic acid
- EPA:
-
Eicosapentaenoic acid
- ERK:
-
Extracellular signal-regulated protein kinase
- GFAP:
-
Glial fibrillary acidic protein
- HEPE:
-
Hydroxyeicosapentaenoic acid
- IKK:
-
IκB kinase
- IL-1:
-
Interleukin 1
- IL-10:
-
Interleukin 10
- IL-1R:
-
Interleukin 1 receptor
- IL-1ra:
-
Interleukin 1 receptor antagonist
- IL-1RAcP:
-
Interleukin 1 receptor accessory protein
- IL-6:
-
Interleukin 6
- IL-6R:
-
Interleukin 6 receptor
- iPLA2:
-
Calcium-independent phospholipase A2
- IRAK:
-
Interleukin-1 receptor associated kinase
- IκB:
-
Inhibitor of κB
- JAK:
-
Janus kinase
- JNK:
-
c-Jun N-terminal kinase
- LA:
-
Linoleic acid
- LOX:
-
Lipoxygenase
- LPS:
-
Lipopolysaccharide
- LT:
-
Leukotriene
- LTP:
-
Long-term potentiation
- LXA4:
-
Lipoxin A4
- LXR:
-
Liver X receptor
- MAPK:
-
Mitogen associated protein (MAP) kinase
- MHCII:
-
Class II major histocompatibility complex
- MK:
-
MAPK-activated protein kinase
- MyD88:
-
Myeloid differentiation primary response gene (88)
- NEMO:
-
NFκB essential modulator
- NFκB:
-
Nuclear factor kappa B
- NIK:
-
NFκB inducing kinase
- PAMP:
-
Pathogen-associated molecular patterns
- PC:
-
Phosphatidylcholine
- PE:
-
Phosphatidylethanolamine
- PG:
-
Prostaglandin
- PGE2:
-
Prostaglandin E2
- PGI:
-
Prostacyclin
- PPAR:
-
Peroxisome proliferator-activated receptor
- PUFA:
-
Polyunsaturated fatty acid
- RXR:
-
Retinoid X receptor
- SAMP8:
-
Senescence-accelerated prone mouse
- STAT:
-
Signal transducers and activators of transcription
- TACE:
-
TNFα cleavage enzyme
- TLR4:
-
Toll-like receptor 4
- TNFR:
-
Tumor necrosis factor receptor
- TNFα:
-
Tumor necrosis factor alpha
- TRADD:
-
TNFR1-associated via death domain
- TRAF-6:
-
TNF receptor associated factor 6
- TX:
-
Thromboxane
- Tyk:
-
Tyrosine kinase 2
References
Bas O, Songur A, Sahin O, Mollaoglu H, Ozen OA, Yaman M, Eser O, Fidan H, Yagmurca M. Neurochem Int. 2007;50:548–54.
Bourre JM, Piciotti M. Neurosci Lett. 1992;141:65–8.
Calder PC. Am J Clin Nutr. 2006;83:1505S–19S.
Calder PC. Biochimie. 2009;91:791–5.
Calon F, Cole G. Prostaglandins Leukot Essent Fatty Acids. 2007;77:287–93.
Chapkin RS, McMurray DN, Davidson LA, Patil BS, Fan YY, Lupton JR. Br J Nutr. 2008;100:1152–7.
Chavali SR, Zhong WW, Forse RA. Prostaglandins Leukot Essent Fatty Acids. 1998;58:185–91.
De Smedt-Peyrusse V, Sargueil F, Moranis A, Harizi H, Mongrand S, Layé S. J Neurochem. 2008;105:296–307.
Dyerberg J, Bang HO. Lancet. 1979;2:433–5.
Dziennis S, Alkayed NJ. Rev Neurosci. 2008;19:341–61.
Ericsson A, Liu C, Hart RP, Sawchenko PE. J Comp Neurol. 1995;361:681–98.
Favrelière S, Perault MC, Huguet F, De Javel D, Bertrand N, Piriou A, Durand G. Neurobiol. Aging. 2003;24:233–43.
Ferrucci L, Cherubini A, Bandinelli S, Bartali B, Corsi A, Lauretani F, Martin A, Andres-Lacueva C, Senin U, Guralnik JM. J Clin Endocrinol Metab. 2006;91:439–46.
Gautron L, Lafon P, Chaigniau M, Tramu G, Layé S. Neuroscience. 2002;112:717–29.
Godbout JP, Chen J, Abraham J, Richwine AF, Berg BM, Kelley KW, Johnson RW. FASEB J. 2005;19:1329–31.
Griffin R, Nally R, Nolan Y, McCartney Y, Linden J, Lynch MA. J Neurochem. 2006;99:1263–72.
Harré EM, Roth J, Pehl U, Kueth M, Gerstberger R, Hübschle T. J Appl Physiol. 2002;92:2657–66.
Jones SA, Richards PJ, Scheller J, Rose-John S. J Interferon Cytokine Res. 2005;25:241–53.
Kaur P, Heggland I, Aschner M, Syversen T. Neurotoxicology. 2008;29:978–87.
Kavanagh T, Lonergan PE, Lynch MA. Prostaglandins Leukot Essent Fatty Acids. 2004;70:391–7.
Kiecolt-Glaser JK, Belury MA, Porter K, Beversdorf DQ, Lemeshow S, Glaser R. Psychosom Med. 2007;69:217–24.
Konsman JP, Vigues S, Mackerlova L, Bristow A, Blomqvist A. J Comp Neurol. 2004;472:113–29.
Legler DF, Micheau O, Doucey MA, Tschopp J, Bron C. Immunity. 2003;18:655–64.
Liu ZG. Cell Res. 2005;15:24–7.
Lukiw WJ, Cui JG, Marcheselli VL, Bodker M, Botkjaer A, Gotlinger K, Serhan CN, Bazan NG. J Clin Invest. 2005;115:2774–83.
Lynch AM, Loane DJ, Minogue AM, Clarke RM, Kilroy D, Nally RE, Roche OJ, O’Connell F, Lynch MA. Neurobiol Aging. 2007;28 (6):845–55.
Lynch AM, Lynch MA. Eur J Neurosci. 2002;15:1779–88.
McCoy MK, Tansey MG. J Neuroinflammation. 2008;5:45.
McGahon BM, Martin DS, Horrobin DF, Lynch MA. Neuroscience. 1999a;94:305–14.
McGahon BM, Murray CA, Horrobin DF, Lynch MA. Neurobiol Aging. 1999b;20:643–53.
Meydani SN, Endres S, Woods MM, Goldin BR, Soo C, Morill-Labrode A, Dinarello CA, Gorbach SL. J Nutrition. 1991;121:547-555.
Michaeli B, Berger MM, Revelly JP, Tappy L, Chiolero R. Clinical nutrition (Edinburgh, Scotland) 2007;26:70-77.
Miguelez M, Anisman H, Weber JM, Merali Z. J Neuroimmunol. 2006;181:19–28.
Mingam R, Moranis A, Bluthé RM, De Smedt-Peyrusse V, Kelley KW, Guesnet P, Lavialle M, Dantzer R, Layé S. Eur J Neurosci. 2008;28:1877–86.
Minogue AM, Lynch AM, Loane DJ, Herron CE, Lynch MA. J Neurochem. 2007;103:914–26.
Nadjar A, Combe C, Layé S, Tridon V, Dantzer R, Amédée T, Parnet P. J Neurochem. 2003;87:1024–36.
Pertusa M, García-Matas S, Rodríguez-Farré E, Sanfeliu C, Cristòfol R. J Neurochem. 2007;101:794–805.
Petursdottir AL, Farr SA, Morley JE, Banks WA, Skuladottir GV. Neurobiol Aging. 2007;28:1170–8.
Pluess TT, Hayoz D, Berger MM, Tappy L, Revelly JP, Michaeli B, Carpentier YA, Chioléro RL. Intensive Care Med. 2007;33:789–97.
Rapoport SI, Rao JS, Igarashi M. Prostaglandins Leukot Essent Fatty Acids. 2007;776:251–61.
Rees D, Miles EA, Banerjee T, Wells SJ, Roynette CE, Wahle KW, Calder PC. Am J Clin Nutr. 2006;83:331–42.
Rothwell NJ, Luheshi GN. Trends Neurosci. 2000;23:618–25.
Scher JU, Pillinger MH. Clin Immunol. 2005;114:100–9.
Sehgal PB, Guo GG, Shah M, Kumar V, Patel K. J Biol Chem. 2002;277:12067–74.
Serhan CN. Prostaglandins Leukot Essent Fatty Acids. 2008;79:157–63.
Simopoulos AP. World Rev Nutr Diet. 2009;99:1–16.
Song C, Horrobin D. J Lipid Res. 2004;45:1112–21.
Tancredi V, D’Antuono M, Cafè C, Giovedì S, Buè MC, D’Arcangelo G, Onofri F, Benfenati F. J Neurochem. 2000;75:634–43.
Triantafilou M, Miyake K, Golenbock DT, Triantafilou K. J Cell Sci. 2002;115:2603–11.
Ye SM, Johnson RW. J Neuroimmunol. 2001;117:87–96.
Acknowledgment
Supported by INRA, CNRS, University of Bordeaux 2, the region Aquitaine and ANR grant ALIA.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Laye, S., Labrousse, V.F., De Smedt-Peyrusse, V. (2011). Dietary n-3-Polyunsaturated Fatty Acid Deprivation and Cytokine Signaling Pathways in the Brain. In: Preedy, V., Watson, R., Martin, C. (eds) Handbook of Behavior, Food and Nutrition. Springer, New York, NY. https://doi.org/10.1007/978-0-387-92271-3_115
Download citation
DOI: https://doi.org/10.1007/978-0-387-92271-3_115
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-92270-6
Online ISBN: 978-0-387-92271-3
eBook Packages: MedicineMedicine (R0)